CFG
MRNA icon

Carr Financial Group’s Moderna MRNA Stock Holding History

Carr Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,156
Closed -$211K – 195
2024
Q3 		$211K Sell
3,156
-1,153
-27% -$106K 0.06% 189
2024
Q2 		$512K Hold
4,309
– – 0.16% 106
2024
Q1 		$459K Hold
4,309
– – 0.15% 109
2023
Q4 		$429K Hold
4,309
– – 0.16% 105
2023
Q3 		$334K Buy
4,309
+880
+26% +$98.2K 0.13% 113
2023
Q2 		$417K Buy
3,429
+2,000
+140% +$267K 0.17% 101
2023
Q1 		$219K Sell
1,429
-25
-2% -$4.12K 0.1% 155
2022
Q4 		$261K Buy
+1,454
New +$238K 0.14% 141

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Carr Financial Group's MRNA Position: Q4 2024 in Review

Carr Financial Group sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,156 shares — an estimated $211K sold.

Carr Financial Group first reported a position in MRNA in Q4 2022 and held it in 8 quarters. The position peaked at $512K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Carr Financial Group reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Carr Financial Group sold 3,156 Moderna shares in Q4 2024, an estimated $211K.
  • Carr Financial Group first reported a position in Moderna in Q4 2022 and held it in 8 quarters.
  • Carr Financial Group's Moderna position peaked at $512K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Carr Financial Group's 13F filing for Q4 2024, filed 21 Jan 2025.